Li W, Wang S, Jin Y, Mu X, Guo Z, Qiao S
Front Microbiol. 2024; 15:1469016.
PMID: 39309526
PMC: 11412822.
DOI: 10.3389/fmicb.2024.1469016.
Komatsu H, Inui A, Hoshino H, Umetsu S, Fujisawa T
JMA J. 2023; 6(4):426-436.
PMID: 37941707
PMC: 10628332.
DOI: 10.31662/jmaj.2023-0082.
Michalak T
Int J Mol Sci. 2023; 24(19).
PMID: 37834296
PMC: 10573506.
DOI: 10.3390/ijms241914849.
Svicher V, Salpini R, DAnna S, Piermatteo L, Iannetta M, Malagnino V
Front Oncol. 2023; 13:1143258.
PMID: 37007163
PMC: 10050604.
DOI: 10.3389/fonc.2023.1143258.
Salpini R, DAnna S, Benedetti L, Piermatteo L, Gill U, Svicher V
Front Microbiol. 2022; 13:972687.
PMID: 36118192
PMC: 9478028.
DOI: 10.3389/fmicb.2022.972687.
Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis.
Coffin C, Mulrooney-Cousins P, Michalak T
Front Microbiol. 2021; 12:695384.
PMID: 34421849
PMC: 8377760.
DOI: 10.3389/fmicb.2021.695384.
Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B.
Michalak T
Front Immunol. 2020; 11:853.
PMID: 32536912
PMC: 7267019.
DOI: 10.3389/fimmu.2020.00853.
The prevalence of occult HBV infection in immunized children with HBsAg-positive parents: a hospital-based analysis.
Zhuge S, Ge C, Yang Y, Cui Y, Yue X, Zhang Z
Hepatol Int. 2020; 14(4):503-512.
PMID: 32472310
PMC: 7259741.
DOI: 10.1007/s12072-020-10055-9.
Hepatitis B Virus e Antigen Regulates Monocyte Function and Promotes B Lymphocyte Activation.
Lu B, Zhang B, Wang L, Ma C, Liu X, Zhao Y
Viral Immunol. 2016; 30(1):35-44.
PMID: 27976981
PMC: 5220529.
DOI: 10.1089/vim.2016.0113.
Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.
Mulrooney-Cousins P, Michalak T
J Clin Transl Hepatol. 2015; 3(3):211-9.
PMID: 26623268
PMC: 4663203.
DOI: 10.14218/JCTH.2015.00020.
Identification of the alternative splicing of the UL49 locus of human cytomegalovirus.
Yang G, Li W, Liao W, Zhang X, Zou Y, Dai J
Biomed Res Int. 2015; 2015:280276.
PMID: 25866769
PMC: 4383306.
DOI: 10.1155/2015/280276.
Primary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocarcinoma in the woodchuck model of hepatitis B.
Mulrooney-Cousins P, Chauhan R, Churchill N, Michalak T
PLoS Pathog. 2014; 10(8):e1004332.
PMID: 25165821
PMC: 4148403.
DOI: 10.1371/journal.ppat.1004332.
Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection.
Tripathy A, Das R, Rathod S, Arankalle V
PLoS One. 2012; 7(2):e31822.
PMID: 22384080
PMC: 3285172.
DOI: 10.1371/journal.pone.0031822.
Pathogenesis of occult chronic hepatitis B virus infection.
Aller de la Fuente R, Gutierrez M, Garcia-Samaniego J, Fernandez-Rodriguez C, Lledo J, Castellano G
World J Gastroenterol. 2011; 17(12):1543-8.
PMID: 21472118
PMC: 3070123.
DOI: 10.3748/wjg.v17.i12.1543.
Viral RNA but no evidence of replication can be detected in the peripheral blood mononuclear cells of hepatitis E virus-infected patients.
Ippagunta S, Naik S, Jameel S, Ramana K, Aggarwal R
J Viral Hepat. 2010; 18(9):668-72.
PMID: 20659304
PMC: 3075346.
DOI: 10.1111/j.1365-2893.2010.01351.x.
Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity.
Mulrooney-Cousins P, Michalak T
J Virol. 2008; 82(15):7540-50.
PMID: 18495768
PMC: 2493328.
DOI: 10.1128/JVI.00405-08.
Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver.
Michalak T, Mulrooney P, Coffin C
J Virol. 2004; 78(4):1730-8.
PMID: 14747538
PMC: 369489.
DOI: 10.1128/jvi.78.4.1730-1738.2004.
In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus.
Lew Y, Michalak T
J Virol. 2001; 75(4):1770-82.
PMID: 11160675
PMC: 114086.
DOI: 10.1128/JVI.75.4.1770-1782.2001.